1 01/06/2024 31/05/2025 2025-05-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2024-06-01 Sage Accounts Production 24.0 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 12603473 2024-06-01 2025-05-31 12603473 2025-05-31 12603473 2024-05-31 12603473 2023-06-01 2024-05-31 12603473 2024-05-31 12603473 2023-05-31 12603473 core:FurnitureFittingsToolsEquipment 2024-06-01 2025-05-31 12603473 bus:LeadAgentIfApplicable 2024-06-01 2025-05-31 12603473 bus:Director1 2024-06-01 2025-05-31 12603473 core:LandBuildings core:OwnedOrFreeholdAssets 2024-05-31 12603473 core:FurnitureFittingsToolsEquipment 2024-05-31 12603473 core:LandBuildings core:OwnedOrFreeholdAssets 2025-05-31 12603473 core:FurnitureFittingsToolsEquipment 2025-05-31 12603473 core:RetainedEarningsAccumulatedLosses 2023-06-01 2024-05-31 12603473 core:RetainedEarningsAccumulatedLosses 2024-06-01 2025-05-31 12603473 core:WithinOneYear 2025-05-31 12603473 core:WithinOneYear 2024-05-31 12603473 core:ShareCapital 2025-05-31 12603473 core:ShareCapital 2024-05-31 12603473 core:RetainedEarningsAccumulatedLosses 2025-05-31 12603473 core:RetainedEarningsAccumulatedLosses 2024-05-31 12603473 core:ShareCapital 2023-05-31 12603473 core:RetainedEarningsAccumulatedLosses 2023-05-31 12603473 core:PreviouslyStatedAmount core:ShareCapital 2025-05-31 12603473 core:LandBuildings core:OwnedOrFreeholdAssets 2024-05-31 12603473 core:FurnitureFittingsToolsEquipment 2024-05-31 12603473 bus:Director1 2024-05-31 12603473 bus:Director1 2025-05-31 12603473 bus:Director1 2023-05-31 12603473 bus:Director1 2024-05-31 12603473 bus:Director1 2023-06-01 2024-05-31 12603473 bus:SmallEntities 2024-06-01 2025-05-31 12603473 bus:AuditExemptWithAccountantsReport 2024-06-01 2025-05-31 12603473 bus:SmallCompaniesRegimeForAccounts 2024-06-01 2025-05-31 12603473 bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 12603473 bus:FullAccounts 2024-06-01 2025-05-31
Company registration number: 12603473
The Prime Clinic
Unaudited filleted financial statements
31 May 2025
The Prime Clinic
Contents
Accountants report
Statement of financial position
Statement of changes in equity
Notes to the financial statements
The Prime Clinic
Report to the director on the preparation of the
unaudited statutory financial statements of The Prime Clinic
Year ended 31 May 2025
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of The Prime Clinic for the year ended 31 May 2025 which comprise the statement of financial position, statement of changes in equity and related notes from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Association of Chartered Certified Accountants , we are subject to its ethical and other professional requirements which are detailed at http://www.accaglobal.com/en/member/ professional-standards/ rules-standards/acca-rulebook.html.
This report is made solely to the director of The Prime Clinic, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of The Prime Clinic and state those matters that we have agreed to state to them, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at https://www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/tf-163-jan-24.pdf. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than The Prime Clinic and its director as a body for our work or for this report.
It is your duty to ensure that The Prime Clinic has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of The Prime Clinic. You consider that The Prime Clinic is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of The Prime Clinic. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Parkinson & Partners
ACCA
Mobbs Wood Farm
Brinklow Road
Ansty
Coventry
CV7 9JN
23 July 2025
The Prime Clinic
Statement of financial position
31 May 2025
2025 2024
Note £ £ £ £
Fixed assets
Tangible assets 5 132,003 138,365
_______ _______
132,003 138,365
Current assets
Debtors 6 2,980 4,239
Cash at bank and in hand 5,319 16,289
_______ _______
8,299 20,528
Creditors: amounts falling due
within one year 7 ( 48,164) ( 81,666)
_______ _______
Net current liabilities ( 39,865) ( 61,138)
_______ _______
Total assets less current liabilities 92,138 77,227
Provisions for liabilities ( 993) ( 2,201)
_______ _______
Net assets 91,145 75,026
_______ _______
Capital and reserves
Called up share capital 1 1
Profit and loss account 91,144 75,025
_______ _______
Shareholder funds 91,145 75,026
_______ _______
For the year ending 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 23 July 2025 , and are signed on behalf of the board by:
Mr R. Mobed
Director
Company registration number: 12603473
The Prime Clinic
Statement of changes in equity
Year ended 31 May 2025
Called up share capital Profit and loss account Total
£ £ £
At 1 June 2023 1 52,577 52,578
Profit for the year 22,448 22,448
_______ _______ _______
Total comprehensive income for the year - 22,448 22,448
_______ _______ _______
At 31 May 2024 and 1 June 2024 1 75,025 75,026
Profit for the year 16,119 16,119
_______ _______ _______
Total comprehensive income for the year - 16,119 16,119
_______ _______ _______
At 31 May 2025 1 91,144 91,145
_______ _______ _______
The Prime Clinic
Notes to the financial statements
Year ended 31 May 2025
1. General information
The company is a private company limited by shares, registered in England. The address of the registered office is 2, Adelaide Road, Leamington Spa, Warwickshire, CV31 3PW.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible assets
tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Fittings fixtures and equipment - 25 % straight line
If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.
Investment property
Investment property is measured initially at cost, which includes purchase price and any directly attributable expenditure. Investment property is revalued to its fair value at each reporting date and any changes in fair value are recognised in profit or loss.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event; it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised in finance costs in profit or loss in the period it arises.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised in finance costs in profit or loss in the period in which it arises.
4. Staff costs
The average number of persons employed by the company during the year amounted to 1 (2024: 1 ).
The aggregate payroll costs incurred during the year were:
2025 2024
£ £
Wages and salaries 12,460 9,577
Social security costs 464 -
Other pension costs 10,000 -
_______ _______
22,924 9,577
_______ _______
5. Tangible assets
Freehold property Fixtures, fittings and equipment Total
£ £ £
Cost
At 1 June 2024 126,779 33,871 160,650
Additions - 573 573
Disposals - ( 2,530) ( 2,530)
_______ _______ _______
At 31 May 2025 126,779 31,914 158,693
_______ _______ _______
Depreciation
At 1 June 2024 - 22,286 22,286
Charge for the year - 6,520 6,520
Disposals - ( 2,116) ( 2,116)
_______ _______ _______
At 31 May 2025 - 26,690 26,690
_______ _______ _______
Carrying amount
At 31 May 2025 126,779 5,224 132,003
_______ _______ _______
At 31 May 2024 126,779 11,585 138,365
_______ _______ _______
Investment property
Included within the above is investment property measured at fair value as follows:
£
At 1 June 2024 and 31 May 2025 126,779
_______
The fair value of the investment property has been arrived at on the basis of a valuation carried out at 31st May 2024 by the Directors. The valuation was made on an open market basis by reference to market evidence of similar properties.
6. Debtors
2025 2024
£ £
Trade debtors 2,639 2,944
Other debtors 341 1,295
_______ _______
2,980 4,239
_______ _______
7. Creditors: amounts falling due within one year
2025 2024
£ £
Corporation tax 5,383 6,388
Other creditors 42,781 75,278
_______ _______
48,164 81,666
_______ _______
8. Directors advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
2025
Balance brought forward Advances /(credits) to the director Amounts repaid Balance o/standing
£ £ £ £
Mr R. Mobed ( 73,514) ( 768) 34,513 ( 39,769)
_______ _______ _______ _______
2024
Balance brought forward Advances /(credits) to the director Amounts repaid Balance o/standing
£ £ £ £
Mr R. Mobed ( 17,333) ( 63,978) 7,797 ( 73,514)
_______ _______ _______ _______
The directors loan is repayable. No interest is charged on the outstanding loan.